Pharmaceuticals

This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.

News
January 22, 2014 β€” The U.S. Food and Drug Administration (FDA)’s Cardiovascular and Renal Drugs Advisory Committee ...
Home January 22, 2014
Home
News
January 22, 2014 β€” The U.S. Food and Drug Administration's (FDA) Cardiovascular and Renal Drugs Advisory Committee voted ...
Home January 22, 2014
Home
News
January 14, 2014 β€” Daiichi Sankyo Company Ltd. announced results from the Phase 3 ENGAGE AF-TIMI 48 study [1]. The ...
Home January 14, 2014
Home
acc pharmaceuticals renal denervation heart valve repair antiplatelet therapy
Feature
December 24, 2013 β€” Clinical trials for a promising new class of cholesterol-lowering medications, a long-awaited repair ...
Home December 24, 2013
Home
Feature
December 23, 2013 β€” Careful documentation of patient selection and procedure appropriateness are critical β€” yet ...
Home December 23, 2013
Home
News
December 17, 2013 β€” CSL Behring announced that Kcentra (Prothrombin Complex Concentrate [Human]) has received U.S. Food ...
Home December 17, 2013
Home
News
December 12, 2013 β€” Thomas Jefferson University researchers discovered that the formation of blood clots follows a ...
Home December 12, 2013
Home
stony brook JAMA cath lab clinical trial study pharmaceuticals angioplasty
Feature
December 11, 2013 β€” For patients with stable coronary artery disease (CAD) who are not experiencing a heart attack and ...
Home December 11, 2013
Home
Feature

November 25, 2013 – Combining genetic data with clinical information to determine the initial dosage of the blood ...

Home November 25, 2013
Home
renal stenting
Feature | Dave Fornell
The use of renal stenting in combination with medication-based therapy to treat hypertension showed no improvement in ...
Home November 19, 2013
Home
Feature
November 15, 2013 β€” The American College of Cardiology (ACC) and the American Heart Association (AHA) released a ...
Home November 15, 2013
Home
News
November 15, 2013 β€” Resverlogix Corp. announced two additional results from the ongoing analysis of its Phase 2b ASSURE ...
Home November 15, 2013
Home
News
November 15, 2013 β€” A study conducted in Ireland found that aspirin does not adequately protect 20 percent of patients ...
Home November 15, 2013
Home
Feature
November 14, 2013 β€” Professional cardiovascular societies and many working cardiologists question the U.S. Food and Drug ...
Home November 14, 2013
Home
News
November 8, 2013 β€” A new way of using blood pressure-lowering medications could prevent more than a fourth of heart ...
Home November 08, 2013
Home
Subscribe Now